Vaccine against porcine parvovirus
The present invention relates i.a. to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid pos...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Utley, Philip Vaughn, Eric Martin Bucklin, Scott Eugene Kroll, Jeremy Kaiser, Troy James |
description | The present invention relates i.a. to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017353378BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017353378BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017353378BB23</originalsourceid><addsrcrecordid>eNrjZFAKS0xOzsxLVUhMT8zMKy5RKMgvAvMLEovK8ssyi0qLeRhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJvGOokYGhubGpsbG5hZOTkTGRygC0zyfC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Vaccine against porcine parvovirus</title><source>esp@cenet</source><creator>Utley, Philip ; Vaughn, Eric Martin ; Bucklin, Scott Eugene ; Kroll, Jeremy ; Kaiser, Troy James</creator><creatorcontrib>Utley, Philip ; Vaughn, Eric Martin ; Bucklin, Scott Eugene ; Kroll, Jeremy ; Kaiser, Troy James</creatorcontrib><description>The present invention relates i.a. to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240314&DB=EPODOC&CC=AU&NR=2017353378B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240314&DB=EPODOC&CC=AU&NR=2017353378B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Utley, Philip</creatorcontrib><creatorcontrib>Vaughn, Eric Martin</creatorcontrib><creatorcontrib>Bucklin, Scott Eugene</creatorcontrib><creatorcontrib>Kroll, Jeremy</creatorcontrib><creatorcontrib>Kaiser, Troy James</creatorcontrib><title>Vaccine against porcine parvovirus</title><description>The present invention relates i.a. to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAKS0xOzsxLVUhMT8zMKy5RKMgvAvMLEovK8ssyi0qLeRhY0xJzilN5oTQ3g4qba4izh25qQX58anFBYnJqXmpJvGOokYGhubGpsbG5hZOTkTGRygC0zyfC</recordid><startdate>20240314</startdate><enddate>20240314</enddate><creator>Utley, Philip</creator><creator>Vaughn, Eric Martin</creator><creator>Bucklin, Scott Eugene</creator><creator>Kroll, Jeremy</creator><creator>Kaiser, Troy James</creator><scope>EVB</scope></search><sort><creationdate>20240314</creationdate><title>Vaccine against porcine parvovirus</title><author>Utley, Philip ; Vaughn, Eric Martin ; Bucklin, Scott Eugene ; Kroll, Jeremy ; Kaiser, Troy James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017353378BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Utley, Philip</creatorcontrib><creatorcontrib>Vaughn, Eric Martin</creatorcontrib><creatorcontrib>Bucklin, Scott Eugene</creatorcontrib><creatorcontrib>Kroll, Jeremy</creatorcontrib><creatorcontrib>Kaiser, Troy James</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Utley, Philip</au><au>Vaughn, Eric Martin</au><au>Bucklin, Scott Eugene</au><au>Kroll, Jeremy</au><au>Kaiser, Troy James</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Vaccine against porcine parvovirus</title><date>2024-03-14</date><risdate>2024</risdate><abstract>The present invention relates i.a. to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2017353378BB2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Vaccine against porcine parvovirus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A32%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Utley,%20Philip&rft.date=2024-03-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017353378BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |